Cheryl Willman

American physician and cancer researcher

Cheryl L. Willman is an American physician and cancer researcher known for her contributions to the field of oncology and her leadership in cancer research institutions. She has played a significant role in advancing the understanding and treatment of leukemia and other cancers.

Early life and education

Cheryl Willman was born and raised in the United States. She pursued her undergraduate studies at St. Olaf College, where she developed an interest in the biological sciences. She later attended the Mayo Clinic Alix School of Medicine, earning her MD degree. During her medical training, she became particularly interested in hematology and oncology, which led her to focus her career on cancer research.

Career

Cheryl Willman, MD

Cheryl Willman began her career in academic medicine, holding various positions at leading medical institutions. She joined the faculty at the University of New Mexico (UNM), where she became a prominent figure in cancer research. At UNM, she served as the Director and CEO of the University of New Mexico Comprehensive Cancer Center, one of the nation's leading cancer research and treatment centers.

Under her leadership, the UNM Comprehensive Cancer Center achieved designation as a National Cancer Institute (NCI) Comprehensive Cancer Center, a prestigious recognition that highlights the center's excellence in cancer research, treatment, and education. Willman's work at the center focused on translational research, aiming to bring scientific discoveries from the laboratory to clinical applications that benefit patients.

Research contributions

Cheryl Willman's research has significantly impacted the understanding of the genetic and molecular basis of leukemia. Her work has involved the use of advanced genomic technologies to identify genetic mutations and alterations that drive the development of leukemia and other cancers. This research has contributed to the development of targeted therapies that improve treatment outcomes for patients.

Willman has also been involved in large-scale collaborative research projects, working with scientists and clinicians across the country to advance cancer research. Her efforts have helped to establish new standards for cancer diagnosis and treatment, particularly in the area of precision medicine.

Awards and recognition

Throughout her career, Cheryl Willman has received numerous awards and honors for her contributions to cancer research and medicine. She has been recognized by professional organizations and institutions for her leadership and innovative research.

Related pages

• Oncology
• Leukemia
• National Cancer Institute
• Precision medicine